company background image
PRM.PRA logo

Big Pharma Split TSX:PRM.PRA Stock Report

Last Price

CA$9.58

Market Cap

CA$15.6m

7D

0%

1Y

5.3%

Updated

18 Apr, 2024

Data

Company Financials

Big Pharma Split Corp.

TSX:PRM.PRA Stock Report

Market Cap: CA$15.6m

PRM.PRA Stock Overview

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc.

PRM.PRA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends3/6

Big Pharma Split Corp. Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Big Pharma Split
Historical stock prices
Current Share PriceCA$9.58
52 Week HighCA$10.78
52 Week LowCA$9.18
Beta0.88
1 Month Change-1.14%
3 Month Change-1.14%
1 Year Change5.27%
3 Year Change-6.81%
5 Year Change-7.53%
Change since IPO-4.49%

Recent News & Updates

Recent updates

Shareholder Returns

PRM.PRACA Capital MarketsCA Market
7D0%-1.8%-2.1%
1Y5.3%19.5%3.6%

Return vs Industry: PRM.PRA underperformed the Canadian Capital Markets industry which returned 19.5% over the past year.

Return vs Market: PRM.PRA exceeded the Canadian Market which returned 3.6% over the past year.

Price Volatility

Is PRM.PRA's price volatile compared to industry and market?
PRM.PRA volatility
PRM.PRA Average Weekly Movementn/a
Capital Markets Industry Average Movement4.3%
Market Average Movement9.2%
10% most volatile stocks in CA Market18.4%
10% least volatile stocks in CA Market3.1%

Stable Share Price: PRM.PRA has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PRM.PRA's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/an/awww.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Big Pharma Split Corp. Fundamentals Summary

How do Big Pharma Split's earnings and revenue compare to its market cap?
PRM.PRA fundamental statistics
Market capCA$15.59m
Earnings (TTM)-CA$645.35k
Revenue (TTM)CA$320.82k

48.2x

P/S Ratio

-24.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PRM.PRA income statement (TTM)
RevenueCA$320.82k
Cost of RevenueCA$0
Gross ProfitCA$320.82k
Other ExpensesCA$966.17k
Earnings-CA$645.35k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.55
Gross Margin100.00%
Net Profit Margin-201.16%
Debt/Equity Ratio65.0%

How did PRM.PRA perform over the long term?

See historical performance and comparison

Dividends

9.3%

Current Dividend Yield

-233%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.